Skip to main content Back to Top
Advertisement

4/25/2018

Procainamide Hydrochloride Injection

Reason for the Shortage

    • Pfizer had procainamide injection on shortage due to manufacturing delays.
    • Nexus Pharmaceuticals launched procainamide injection in October 2017.

Available Products

    • Procainamide Hydrochloride injection, Amphastar, 100 mg/mL, 10 mL Luer Lock syringe, 5 count, NDC 76329-3399-05
    • Procainamide Hydrochloride injection, Nexus Pharmaceuticals, 100 mg/mL, 10 mL multiple dose vial, 10 count, NDC 14789-0900-10
    • Procainamide Hydrochloride injection, Nexus Pharmaceuticals, 500 mg/mL, 2 mL multiple dose vial, 10 count, NDC 14789-0900-02
    • Procainamide Hydrochloride injection, Pfizer, 100 mg/mL, 10 mL vial, 25 count, NDC 00409-1902-01
    • Procainamide Hydrochloride injection, Pfizer, 500 mg/mL, 2 mL vial, 25 count, NDC 00409-1903-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated April 25, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 2, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins